Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.09699459 |
2 | L-phenylalanine catabolic process (GO:0006559) | 6.09699459 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.72317843 |
4 | L-phenylalanine metabolic process (GO:0006558) | 5.72317843 |
5 | Golgi transport vesicle coating (GO:0048200) | 5.41075212 |
6 | COPI coating of Golgi vesicle (GO:0048205) | 5.41075212 |
7 | aromatic amino acid family catabolic process (GO:0009074) | 5.07953075 |
8 | L-alpha-amino acid transmembrane transport (GO:1902475) | 4.97303824 |
9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.96058811 |
10 | behavioral response to nicotine (GO:0035095) | 4.72401172 |
11 | intestinal cholesterol absorption (GO:0030299) | 4.66845653 |
12 | piRNA metabolic process (GO:0034587) | 4.58558101 |
13 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.39694975 |
14 | protein carboxylation (GO:0018214) | 4.39694975 |
15 | cysteine metabolic process (GO:0006534) | 4.24920672 |
16 | complement activation, alternative pathway (GO:0006957) | 4.21674917 |
17 | urea metabolic process (GO:0019627) | 4.19578109 |
18 | urea cycle (GO:0000050) | 4.19578109 |
19 | tryptophan catabolic process (GO:0006569) | 4.17605584 |
20 | indole-containing compound catabolic process (GO:0042436) | 4.17605584 |
21 | indolalkylamine catabolic process (GO:0046218) | 4.17605584 |
22 | tryptophan metabolic process (GO:0006568) | 4.15702972 |
23 | alpha-linolenic acid metabolic process (GO:0036109) | 4.14635190 |
24 | COPII vesicle coating (GO:0048208) | 4.11449976 |
25 | bile acid biosynthetic process (GO:0006699) | 4.08799436 |
26 | high-density lipoprotein particle remodeling (GO:0034375) | 4.06293750 |
27 | kynurenine metabolic process (GO:0070189) | 4.04864784 |
28 | phospholipid efflux (GO:0033700) | 4.03780535 |
29 | sulfur amino acid catabolic process (GO:0000098) | 3.92510324 |
30 | nitrogen cycle metabolic process (GO:0071941) | 3.85752768 |
31 | regulation of cholesterol homeostasis (GO:2000188) | 3.85191430 |
32 | regulation of triglyceride catabolic process (GO:0010896) | 3.85157678 |
33 | reverse cholesterol transport (GO:0043691) | 3.84510865 |
34 | glyoxylate metabolic process (GO:0046487) | 3.84011731 |
35 | lysine metabolic process (GO:0006553) | 3.82169644 |
36 | lysine catabolic process (GO:0006554) | 3.82169644 |
37 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.81921527 |
38 | intestinal absorption (GO:0050892) | 3.81598374 |
39 | endocrine pancreas development (GO:0031018) | 3.81085235 |
40 | plasma lipoprotein particle clearance (GO:0034381) | 3.80784975 |
41 | bile acid metabolic process (GO:0008206) | 3.80355263 |
42 | triglyceride homeostasis (GO:0070328) | 3.78729024 |
43 | acylglycerol homeostasis (GO:0055090) | 3.78729024 |
44 | plasma lipoprotein particle assembly (GO:0034377) | 3.78623483 |
45 | regulation of protein activation cascade (GO:2000257) | 3.78192581 |
46 | cellular biogenic amine catabolic process (GO:0042402) | 3.77069881 |
47 | amine catabolic process (GO:0009310) | 3.77069881 |
48 | tyrosine metabolic process (GO:0006570) | 3.77048250 |
49 | homocysteine metabolic process (GO:0050667) | 3.67817132 |
50 | negative regulation of fibrinolysis (GO:0051918) | 3.65146692 |
51 | aromatic amino acid family metabolic process (GO:0009072) | 3.64556758 |
52 | peptide hormone processing (GO:0016486) | 3.63268866 |
53 | plasma lipoprotein particle remodeling (GO:0034369) | 3.61055289 |
54 | protein-lipid complex remodeling (GO:0034368) | 3.61055289 |
55 | macromolecular complex remodeling (GO:0034367) | 3.61055289 |
56 | cholesterol efflux (GO:0033344) | 3.60895984 |
57 | regulation of cholesterol esterification (GO:0010872) | 3.59938862 |
58 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.56517462 |
59 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.56517462 |
60 | NADH dehydrogenase complex assembly (GO:0010257) | 3.56517462 |
61 | male meiosis I (GO:0007141) | 3.56407908 |
62 | regulation of complement activation (GO:0030449) | 3.54574650 |
63 | synapsis (GO:0007129) | 3.54268827 |
64 | platelet dense granule organization (GO:0060155) | 3.53336843 |
65 | regulation of fibrinolysis (GO:0051917) | 3.52315863 |
66 | serine family amino acid catabolic process (GO:0009071) | 3.51971486 |
67 | drug transmembrane transport (GO:0006855) | 3.50711936 |
68 | L-fucose catabolic process (GO:0042355) | 3.48900375 |
69 | fucose catabolic process (GO:0019317) | 3.48900375 |
70 | L-fucose metabolic process (GO:0042354) | 3.48900375 |
71 | regulation of meiosis I (GO:0060631) | 3.48653469 |
72 | bile acid and bile salt transport (GO:0015721) | 3.48429915 |
73 | positive regulation of heat generation (GO:0031652) | 3.42537082 |
74 | negative regulation of cholesterol transport (GO:0032375) | 3.42040713 |
75 | negative regulation of sterol transport (GO:0032372) | 3.42040713 |
76 | cellular response to ATP (GO:0071318) | 3.39874456 |
77 | protein-lipid complex assembly (GO:0065005) | 3.38938733 |
78 | lipoprotein metabolic process (GO:0042157) | 3.36469774 |
79 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.34954260 |
80 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.34416285 |
81 | amino-acid betaine metabolic process (GO:0006577) | 3.34187168 |
82 | DNA methylation involved in gamete generation (GO:0043046) | 3.30004939 |
83 | magnesium ion transport (GO:0015693) | 3.29478927 |
84 | response to pheromone (GO:0019236) | 3.27049401 |
85 | indole-containing compound metabolic process (GO:0042430) | 3.26698438 |
86 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.24495196 |
87 | indolalkylamine metabolic process (GO:0006586) | 3.24133008 |
88 | macroautophagy (GO:0016236) | 3.23627619 |
89 | male meiosis (GO:0007140) | 3.21587229 |
90 | negative regulation of digestive system process (GO:0060457) | 3.19463331 |
91 | plasma lipoprotein particle organization (GO:0071827) | 3.19073685 |
92 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.17854291 |
93 | alpha-amino acid catabolic process (GO:1901606) | 3.17244151 |
94 | positive regulation of prostaglandin secretion (GO:0032308) | 3.17226716 |
95 | phospholipid homeostasis (GO:0055091) | 3.16053812 |
96 | mitochondrial calcium ion transport (GO:0006851) | 3.15313271 |
97 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.14027372 |
98 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.14027372 |
99 | cholesterol homeostasis (GO:0042632) | 3.11793150 |
100 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.10999494 |
101 | low-density lipoprotein particle clearance (GO:0034383) | 3.10751280 |
102 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.10034170 |
103 | sterol homeostasis (GO:0055092) | 3.09379396 |
104 | regulation of heat generation (GO:0031650) | 3.08346477 |
105 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.06969258 |
106 | neural tube formation (GO:0001841) | 3.04505753 |
107 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.04420644 |
108 | positive regulation of glycolytic process (GO:0045821) | 3.02968358 |
109 | protein complex biogenesis (GO:0070271) | 3.02859646 |
110 | positive regulation of lipid catabolic process (GO:0050996) | 3.02154710 |
111 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.02000627 |
112 | NAD biosynthetic process (GO:0009435) | 3.01448901 |
113 | regulation of bile acid biosynthetic process (GO:0070857) | 3.00278838 |
114 | protein-lipid complex subunit organization (GO:0071825) | 2.99872849 |
115 | coenzyme catabolic process (GO:0009109) | 2.96950927 |
116 | drug catabolic process (GO:0042737) | 2.96155579 |
117 | protein retention in ER lumen (GO:0006621) | 2.95294096 |
118 | drug transport (GO:0015893) | 2.94955431 |
119 | cellular modified amino acid catabolic process (GO:0042219) | 2.94559967 |
120 | cellular amino acid catabolic process (GO:0009063) | 2.93414543 |
121 | cellular ketone body metabolic process (GO:0046950) | 2.93287715 |
122 | positive regulation of meiosis (GO:0045836) | 2.93095574 |
123 | urate metabolic process (GO:0046415) | 2.91153894 |
124 | protein K11-linked deubiquitination (GO:0035871) | 2.90769402 |
125 | valine metabolic process (GO:0006573) | 2.90322297 |
126 | cofactor catabolic process (GO:0051187) | 2.89603278 |
127 | positive regulation of nuclease activity (GO:0032075) | 2.89507316 |
128 | fatty acid oxidation (GO:0019395) | 2.88815788 |
129 | glycine metabolic process (GO:0006544) | 2.88441727 |
130 | glutamate metabolic process (GO:0006536) | 2.87929918 |
131 | proline transport (GO:0015824) | 2.87666527 |
132 | cholesterol transport (GO:0030301) | 2.87202780 |
133 | negative regulation of mast cell activation (GO:0033004) | 2.86293994 |
134 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.84725219 |
135 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.82839293 |
136 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.82077620 |
137 | response to caffeine (GO:0031000) | 2.81465026 |
138 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.80219782 |
139 | alanine transport (GO:0032328) | 2.76194626 |
140 | regulation of fever generation (GO:0031620) | 2.75449927 |
141 | positive regulation of meiotic cell cycle (GO:0051446) | 2.73918914 |
142 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.72595769 |
143 | detection of light stimulus involved in visual perception (GO:0050908) | 2.66711249 |
144 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.66711249 |
145 | oxidative demethylation (GO:0070989) | 2.66646080 |
146 | regulation of prostaglandin secretion (GO:0032306) | 2.64110735 |
147 | DNA deamination (GO:0045006) | 2.63739053 |
148 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.62207382 |
149 | synaptic transmission, cholinergic (GO:0007271) | 2.60311468 |
150 | ubiquinone biosynthetic process (GO:0006744) | 2.60004205 |
151 | sulfation (GO:0051923) | 2.59536026 |
152 | positive regulation of fatty acid transport (GO:2000193) | 2.59103693 |
153 | ovulation from ovarian follicle (GO:0001542) | 2.58381554 |
154 | basic amino acid transport (GO:0015802) | 2.58009208 |
155 | regulation of chronic inflammatory response (GO:0002676) | 2.57055676 |
156 | glycerophospholipid catabolic process (GO:0046475) | 2.55015821 |
157 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.53670862 |
158 | regulation of gene silencing by miRNA (GO:0060964) | 2.53670862 |
159 | regulation of gene silencing by RNA (GO:0060966) | 2.53670862 |
160 | kidney morphogenesis (GO:0060993) | 2.51979585 |
161 | positive regulation of defense response to virus by host (GO:0002230) | 2.51321322 |
162 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.50382085 |
163 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.50259265 |
164 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.49963768 |
165 | meiosis I (GO:0007127) | 2.49641131 |
166 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.46981245 |
167 | positive regulation of icosanoid secretion (GO:0032305) | 2.46589330 |
168 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.45525575 |
169 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.45525575 |
170 | protein K6-linked ubiquitination (GO:0085020) | 2.43178485 |
171 | benzene-containing compound metabolic process (GO:0042537) | 2.41321889 |
172 | vitamin biosynthetic process (GO:0009110) | 2.40498895 |
173 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.38498020 |
174 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.33799123 |
175 | multicellular organism reproduction (GO:0032504) | 2.32942582 |
176 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.31336421 |
177 | spinal cord motor neuron differentiation (GO:0021522) | 2.31164890 |
178 | pseudouridine synthesis (GO:0001522) | 2.31087425 |
179 | double-strand break repair via homologous recombination (GO:0000724) | 2.30996096 |
180 | sphingoid metabolic process (GO:0046519) | 2.30588257 |
181 | recombinational repair (GO:0000725) | 2.29797928 |
182 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.29529745 |
183 | prostate gland growth (GO:0060736) | 2.29479951 |
184 | photoreceptor cell maintenance (GO:0045494) | 2.28062655 |
185 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.25078117 |
186 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.25078117 |
187 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.24431940 |
188 | ubiquinone metabolic process (GO:0006743) | 2.23447268 |
189 | reciprocal DNA recombination (GO:0035825) | 2.22556194 |
190 | reciprocal meiotic recombination (GO:0007131) | 2.22556194 |
191 | otic vesicle formation (GO:0030916) | 2.21809183 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.57109464 |
2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.43417196 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.64751626 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.12773776 |
5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.10262452 |
6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.93755018 |
7 | GATA1_22025678_ChIP-Seq_K562_Human | 4.53909404 |
8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.14066418 |
9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.12714086 |
10 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.67088386 |
11 | VDR_22108803_ChIP-Seq_LS180_Human | 3.58207376 |
12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.23825119 |
13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.16552308 |
14 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.13241311 |
15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.11324711 |
16 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.06064865 |
17 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.74525091 |
18 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.71600138 |
19 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.40737695 |
20 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.34628156 |
21 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.31738606 |
22 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.26233979 |
23 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.21650943 |
24 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.18227152 |
25 | EWS_26573619_Chip-Seq_HEK293_Human | 2.14737597 |
26 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.13887131 |
27 | P300_19829295_ChIP-Seq_ESCs_Human | 2.02401242 |
28 | FUS_26573619_Chip-Seq_HEK293_Human | 2.01052772 |
29 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.99483063 |
30 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.91728534 |
31 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.90427361 |
32 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.87268915 |
33 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.84352624 |
34 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.79228814 |
35 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.79226653 |
36 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.78045826 |
37 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.76514144 |
38 | GATA1_19941826_ChIP-Seq_K562_Human | 1.76374366 |
39 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.72390753 |
40 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.72390753 |
41 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.71046579 |
42 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.69491746 |
43 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.65238333 |
44 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.62627564 |
45 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.62343034 |
46 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.61516199 |
47 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.58480865 |
48 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.56253606 |
49 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.56253606 |
50 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.55755376 |
51 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.54670970 |
52 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.52987101 |
53 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.51943219 |
54 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.48560646 |
55 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.48373484 |
56 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.48373484 |
57 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.47958820 |
58 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.47290743 |
59 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.47116703 |
60 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.45968753 |
61 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.45605652 |
62 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.45430113 |
63 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.44071562 |
64 | STAT3_23295773_ChIP-Seq_U87_Human | 1.43645191 |
65 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.40896027 |
66 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.40170472 |
67 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.39775045 |
68 | TCF4_23295773_ChIP-Seq_U87_Human | 1.38451525 |
69 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.36940464 |
70 | * TP53_22573176_ChIP-Seq_HFKS_Human | 1.36083819 |
71 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.35359419 |
72 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.35266632 |
73 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.35001639 |
74 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.34549911 |
75 | AR_25329375_ChIP-Seq_VCAP_Human | 1.33792888 |
76 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.33235619 |
77 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.31869570 |
78 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.29847304 |
79 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.29477407 |
80 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.29277815 |
81 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.28800255 |
82 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.26571007 |
83 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.26326931 |
84 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.26162099 |
85 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.26062361 |
86 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.24346466 |
87 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.24346466 |
88 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.24205941 |
89 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.24092962 |
90 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.23179906 |
91 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.22968628 |
92 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.22178223 |
93 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.21211752 |
94 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.21053527 |
95 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.20878289 |
96 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.19611381 |
97 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.19087046 |
98 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.18365108 |
99 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.17651708 |
100 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.16802722 |
101 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.16647853 |
102 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.15516965 |
103 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.14649645 |
104 | GATA2_19941826_ChIP-Seq_K562_Human | 1.14543850 |
105 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13914075 |
106 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.13635778 |
107 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.13403156 |
108 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.12253383 |
109 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.10938633 |
110 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.10080736 |
111 | AR_20517297_ChIP-Seq_VCAP_Human | 1.09802595 |
112 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.09396909 |
113 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.09367429 |
114 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.09159558 |
115 | NCOR_22424771_ChIP-Seq_293T_Human | 1.08958813 |
116 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.08450059 |
117 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.07503756 |
118 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.05930797 |
119 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05239400 |
120 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.04331837 |
121 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.04264528 |
122 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.04233677 |
123 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03878304 |
124 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.03408517 |
125 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.03173385 |
126 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.02738192 |
127 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.02727097 |
128 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.01611504 |
129 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.01090107 |
130 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.00821853 |
131 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.00269910 |
132 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.99544463 |
133 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.97926914 |
134 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.97754854 |
135 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.97578015 |
136 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.97419774 |
137 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.96962248 |
138 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.96758073 |
139 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.96011687 |
140 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.95756347 |
141 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.95713401 |
142 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.95458498 |
143 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.94429524 |
144 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.94374265 |
145 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.94252719 |
146 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.93051826 |
147 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.93048675 |
148 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.92669564 |
149 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.92215397 |
150 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91682143 |
151 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.89752798 |
152 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.88540205 |
153 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.87683193 |
154 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87001982 |
155 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86474926 |
156 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.85475211 |
157 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83582922 |
158 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.82576593 |
159 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80740276 |
160 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.79724338 |
161 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.79101654 |
162 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78105543 |
163 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78103634 |
164 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.77386006 |
165 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.75777255 |
166 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.74576387 |
167 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.74156981 |
168 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.73968761 |
169 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.73278221 |
170 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.72046373 |
171 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.71981587 |
172 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.71789326 |
173 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70235740 |
174 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.70086509 |
175 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.69784332 |
176 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.69680225 |
177 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.68895197 |
178 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.68892322 |
179 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.68705407 |
180 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.67585232 |
181 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.66313826 |
182 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.66155364 |
183 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.65075642 |
184 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.64991942 |
185 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.64651004 |
186 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.63410058 |
187 | SPI1_23127762_ChIP-Seq_K562_Human | 0.63063247 |
188 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.62567078 |
189 | * HTT_18923047_ChIP-ChIP_STHdh_Human | 0.62273718 |
190 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.61274539 |
191 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.61177239 |
192 | UTX_26944678_Chip-Seq_JUKART_Human | 0.61119263 |
193 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.61007437 |
194 | GATA3_26560356_Chip-Seq_TH2_Human | 0.60638191 |
195 | MYB_26560356_Chip-Seq_TH1_Human | 0.59646222 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 6.32810818 |
2 | MP0005360_urolithiasis | 5.48843869 |
3 | MP0003646_muscle_fatigue | 4.88472437 |
4 | MP0005365_abnormal_bile_salt | 4.75610597 |
5 | MP0005085_abnormal_gallbladder_physiolo | 4.53634992 |
6 | MP0003195_calcinosis | 4.23858033 |
7 | MP0003252_abnormal_bile_duct | 3.60225733 |
8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.41522817 |
9 | MP0009840_abnormal_foam_cell | 3.41023151 |
10 | MP0008877_abnormal_DNA_methylation | 2.89155438 |
11 | MP0003806_abnormal_nucleotide_metabolis | 2.73295219 |
12 | MP0005083_abnormal_biliary_tract | 2.73123506 |
13 | MP0002877_abnormal_melanocyte_morpholog | 2.69087431 |
14 | MP0010329_abnormal_lipoprotein_level | 2.67820408 |
15 | MP0001666_abnormal_nutrient_absorption | 2.52123769 |
16 | MP0003183_abnormal_peptide_metabolism | 2.42522334 |
17 | MP0005167_abnormal_blood-brain_barrier | 2.36445488 |
18 | MP0002138_abnormal_hepatobiliary_system | 2.32740944 |
19 | MP0003656_abnormal_erythrocyte_physiolo | 2.20072114 |
20 | MP0002693_abnormal_pancreas_physiology | 2.02333895 |
21 | MP0004043_abnormal_pH_regulation | 2.01963287 |
22 | MP0003191_abnormal_cellular_cholesterol | 2.01207774 |
23 | MP0005332_abnormal_amino_acid | 2.00908661 |
24 | MP0000609_abnormal_liver_physiology | 2.00669845 |
25 | MP0002148_abnormal_hypersensitivity_rea | 1.97402892 |
26 | MP0004145_abnormal_muscle_electrophysio | 1.91084127 |
27 | MP0005645_abnormal_hypothalamus_physiol | 1.90296125 |
28 | MP0001944_abnormal_pancreas_morphology | 1.86497970 |
29 | MP0009046_muscle_twitch | 1.85693271 |
30 | MP0005551_abnormal_eye_electrophysiolog | 1.83830303 |
31 | MP0001501_abnormal_sleep_pattern | 1.81948967 |
32 | MP0003868_abnormal_feces_composition | 1.81900474 |
33 | MP0002118_abnormal_lipid_homeostasis | 1.79070868 |
34 | MP0000569_abnormal_digit_pigmentation | 1.78278774 |
35 | MP0005058_abnormal_lysosome_morphology | 1.76342458 |
36 | MP0002102_abnormal_ear_morphology | 1.76279522 |
37 | MP0003300_gastrointestinal_ulcer | 1.76190842 |
38 | MP0009643_abnormal_urine_homeostasis | 1.73733298 |
39 | MP0002078_abnormal_glucose_homeostasis | 1.68922313 |
40 | MP0002909_abnormal_adrenal_gland | 1.68779985 |
41 | MP0000013_abnormal_adipose_tissue | 1.67848609 |
42 | MP0002277_abnormal_respiratory_mucosa | 1.66802925 |
43 | MP0000372_irregular_coat_pigmentation | 1.64723906 |
44 | MP0004019_abnormal_vitamin_homeostasis | 1.64219279 |
45 | MP0005220_abnormal_exocrine_pancreas | 1.63820078 |
46 | MP0003136_yellow_coat_color | 1.60178857 |
47 | MP0005646_abnormal_pituitary_gland | 1.59438769 |
48 | MP0000383_abnormal_hair_follicle | 1.55991249 |
49 | MP0005174_abnormal_tail_pigmentation | 1.55382566 |
50 | MP0005319_abnormal_enzyme/_coenzyme | 1.55323734 |
51 | MP0005379_endocrine/exocrine_gland_phen | 1.54808332 |
52 | MP0000427_abnormal_hair_cycle | 1.50498940 |
53 | MP0002876_abnormal_thyroid_physiology | 1.50113159 |
54 | MP0005636_abnormal_mineral_homeostasis | 1.41406213 |
55 | MP0005253_abnormal_eye_physiology | 1.39289209 |
56 | MP0005671_abnormal_response_to | 1.34792870 |
57 | MP0004264_abnormal_extraembryonic_tissu | 1.34407692 |
58 | MP0001764_abnormal_homeostasis | 1.33963449 |
59 | MP0004742_abnormal_vestibular_system | 1.33055350 |
60 | MP0003172_abnormal_lysosome_physiology | 1.31023274 |
61 | MP0002653_abnormal_ependyma_morphology | 1.27400813 |
62 | MP0009780_abnormal_chondrocyte_physiolo | 1.26339876 |
63 | MP0002837_dystrophic_cardiac_calcinosis | 1.26180738 |
64 | MP0009745_abnormal_behavioral_response | 1.25417464 |
65 | MP0005310_abnormal_salivary_gland | 1.22074826 |
66 | MP0004142_abnormal_muscle_tone | 1.21765719 |
67 | MP0008872_abnormal_physiological_respon | 1.21480910 |
68 | MP0004510_myositis | 1.21128297 |
69 | MP0002638_abnormal_pupillary_reflex | 1.20129683 |
70 | MP0005410_abnormal_fertilization | 1.18097894 |
71 | MP0005389_reproductive_system_phenotype | 1.18060439 |
72 | MP0001485_abnormal_pinna_reflex | 1.16814808 |
73 | MP0001756_abnormal_urination | 1.16777815 |
74 | MP0002160_abnormal_reproductive_system | 1.16119957 |
75 | MP0008469_abnormal_protein_level | 1.14649237 |
76 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.13692417 |
77 | MP0000598_abnormal_liver_morphology | 1.12782996 |
78 | MP0005647_abnormal_sex_gland | 1.11019716 |
79 | MP0002095_abnormal_skin_pigmentation | 1.10238531 |
80 | MP0002928_abnormal_bile_duct | 1.09822299 |
81 | MP0004215_abnormal_myocardial_fiber | 1.09552867 |
82 | MP0002938_white_spotting | 1.08919756 |
83 | MP0006072_abnormal_retinal_apoptosis | 1.08246409 |
84 | MP0005670_abnormal_white_adipose | 1.08002250 |
85 | MP0003436_decreased_susceptibility_to | 1.07490127 |
86 | MP0000003_abnormal_adipose_tissue | 1.07029028 |
87 | MP0002332_abnormal_exercise_endurance | 1.06510517 |
88 | MP0002064_seizures | 1.06088745 |
89 | MP0003186_abnormal_redox_activity | 1.03078688 |
90 | MP0008057_abnormal_DNA_replication | 1.02962353 |
91 | MP0005408_hypopigmentation | 1.00820754 |
92 | MP0009642_abnormal_blood_homeostasis | 1.00794928 |
93 | MP0001919_abnormal_reproductive_system | 1.00471298 |
94 | MP0000631_abnormal_neuroendocrine_gland | 0.99709584 |
95 | MP0000604_amyloidosis | 0.99167896 |
96 | MP0001765_abnormal_ion_homeostasis | 0.99143500 |
97 | MP0004147_increased_porphyrin_level | 0.96758099 |
98 | MP0001324_abnormal_eye_pigmentation | 0.95021806 |
99 | MP0000371_diluted_coat_color | 0.94744270 |
100 | MP0003718_maternal_effect | 0.94412375 |
101 | MP0002210_abnormal_sex_determination | 0.94101320 |
102 | MP0005334_abnormal_fat_pad | 0.94015096 |
103 | MP0009763_increased_sensitivity_to | 0.93941315 |
104 | MP0005464_abnormal_platelet_physiology | 0.93878445 |
105 | MP0000678_abnormal_parathyroid_gland | 0.93344424 |
106 | MP0003698_abnormal_male_reproductive | 0.92509438 |
107 | MP0003303_peritoneal_inflammation | 0.92180381 |
108 | MP0003283_abnormal_digestive_organ | 0.90431257 |
109 | MP0005535_abnormal_body_temperature | 0.90085361 |
110 | MP0005448_abnormal_energy_balance | 0.89719083 |
111 | MP0003953_abnormal_hormone_level | 0.88838272 |
112 | MP0009764_decreased_sensitivity_to | 0.88586096 |
113 | MP0001929_abnormal_gametogenesis | 0.88250469 |
114 | MP0002163_abnormal_gland_morphology | 0.88029932 |
115 | MP0001968_abnormal_touch/_nociception | 0.85202061 |
116 | MP0005084_abnormal_gallbladder_morpholo | 0.84009623 |
117 | MP0000647_abnormal_sebaceous_gland | 0.83649029 |
118 | MP0004130_abnormal_muscle_cell | 0.82944235 |
119 | MP0010678_abnormal_skin_adnexa | 0.80750387 |
120 | MP0003724_increased_susceptibility_to | 0.80651808 |
121 | MP0005386_behavior/neurological_phenoty | 0.80027352 |
122 | MP0004924_abnormal_behavior | 0.80027352 |
123 | MP0009697_abnormal_copulation | 0.78904227 |
124 | MP0006036_abnormal_mitochondrial_physio | 0.78236856 |
125 | MP0008961_abnormal_basal_metabolism | 0.78188057 |
126 | MP0010386_abnormal_urinary_bladder | 0.78029615 |
127 | MP0005375_adipose_tissue_phenotype | 0.77016033 |
128 | MP0002971_abnormal_brown_adipose | 0.77005296 |
129 | MP0004947_skin_inflammation | 0.76730247 |
130 | MP0002229_neurodegeneration | 0.75475183 |
131 | MP0001845_abnormal_inflammatory_respons | 0.75373405 |
132 | MP0000653_abnormal_sex_gland | 0.75306960 |
133 | MP0003959_abnormal_lean_body | 0.75257428 |
134 | MP0006292_abnormal_olfactory_placode | 0.73807644 |
135 | MP0001145_abnormal_male_reproductive | 0.72045060 |
136 | MP0002272_abnormal_nervous_system | 0.71857285 |
137 | MP0003137_abnormal_impulse_conducting | 0.71419328 |
138 | MP0006054_spinal_hemorrhage | 0.71224539 |
139 | MP0002733_abnormal_thermal_nociception | 0.70538726 |
140 | MP0003705_abnormal_hypodermis_morpholog | 0.69844078 |
141 | MP0005195_abnormal_posterior_eye | 0.69290270 |
142 | MP0000015_abnormal_ear_pigmentation | 0.69215820 |
143 | MP0002136_abnormal_kidney_physiology | 0.67466000 |
144 | MP0001800_abnormal_humoral_immune | 0.66685248 |
145 | MP0001970_abnormal_pain_threshold | 0.64744672 |
146 | MP0002419_abnormal_innate_immunity | 0.64368238 |
147 | MP0006082_CNS_inflammation | 0.64213534 |
148 | MP0009765_abnormal_xenobiotic_induced | 0.62914984 |
149 | MP0002896_abnormal_bone_mineralization | 0.62185755 |
150 | MP0000639_abnormal_adrenal_gland | 0.61863149 |
151 | MP0005666_abnormal_adipose_tissue | 0.60105782 |
152 | MP0000230_abnormal_systemic_arterial | 0.59067412 |
153 | MP0001533_abnormal_skeleton_physiology | 0.56196682 |
154 | MP0005451_abnormal_body_composition | 0.56158595 |
155 | MP0002970_abnormal_white_adipose | 0.55360754 |
156 | MP0005376_homeostasis/metabolism_phenot | 0.53775038 |
157 | MP0009672_abnormal_birth_weight | 0.52666629 |
158 | MP0005025_abnormal_response_to | 0.51486871 |
159 | MP0001661_extended_life_span | 0.50130557 |
160 | MP0004185_abnormal_adipocyte_glucose | 0.50116324 |
161 | MP0005266_abnormal_metabolism | 0.47863156 |
162 | MP0005387_immune_system_phenotype | 0.47847043 |
163 | MP0001790_abnormal_immune_system | 0.47847043 |
164 | MP0003075_altered_response_to | 0.46774990 |
165 | MP0002254_reproductive_system_inflammat | 0.46693916 |
166 | MP0009785_altered_susceptibility_to | 0.46427197 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hypoglycemic coma (HP:0001325) | 5.84973398 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.76841533 |
3 | Hyperinsulinemic hypoglycemia (HP:0000825) | 5.45240883 |
4 | Intrahepatic cholestasis (HP:0001406) | 5.43936296 |
5 | Hypoglycemic seizures (HP:0002173) | 5.29499132 |
6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.86432196 |
7 | Xanthomatosis (HP:0000991) | 4.77284949 |
8 | Ketoacidosis (HP:0001993) | 4.47312390 |
9 | Symptomatic seizures (HP:0011145) | 4.41179651 |
10 | Deep venous thrombosis (HP:0002625) | 4.36903143 |
11 | Prolonged partial thromboplastin time (HP:0003645) | 4.26254453 |
12 | Ketosis (HP:0001946) | 4.16403483 |
13 | Hypobetalipoproteinemia (HP:0003563) | 4.11584816 |
14 | Pancreatic cysts (HP:0001737) | 4.03813848 |
15 | Hyperglycemia (HP:0003074) | 4.01409480 |
16 | Abnormality of the common coagulation pathway (HP:0010990) | 4.01166078 |
17 | Conjugated hyperbilirubinemia (HP:0002908) | 3.97296412 |
18 | Abnormality of the intrinsic pathway (HP:0010989) | 3.92527797 |
19 | Complement deficiency (HP:0004431) | 3.90031428 |
20 | Late onset (HP:0003584) | 3.72006331 |
21 | Molar tooth sign on MRI (HP:0002419) | 3.56904929 |
22 | Abnormality of midbrain morphology (HP:0002418) | 3.56904929 |
23 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.50894881 |
24 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.48460454 |
25 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.48460454 |
26 | Hyperlipoproteinemia (HP:0010980) | 3.45569140 |
27 | Epidermoid cyst (HP:0200040) | 3.43096041 |
28 | Joint hemorrhage (HP:0005261) | 3.39510221 |
29 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.31879842 |
30 | Hyperbilirubinemia (HP:0002904) | 3.27643120 |
31 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.24761746 |
32 | Abnormality of alanine metabolism (HP:0010916) | 3.24761746 |
33 | Hyperalaninemia (HP:0003348) | 3.24761746 |
34 | Hypolipoproteinemia (HP:0010981) | 3.20850364 |
35 | Acanthocytosis (HP:0001927) | 3.18370639 |
36 | Pancreatic fibrosis (HP:0100732) | 3.12913512 |
37 | Fat malabsorption (HP:0002630) | 3.12037668 |
38 | True hermaphroditism (HP:0010459) | 3.06063059 |
39 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.04647949 |
40 | Abnormal drinking behavior (HP:0030082) | 3.00949279 |
41 | Polydipsia (HP:0001959) | 3.00949279 |
42 | Skin nodule (HP:0200036) | 3.00785663 |
43 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.98749281 |
44 | Congenital stationary night blindness (HP:0007642) | 2.98723401 |
45 | Mucopolysacchariduria (HP:0008155) | 2.95947719 |
46 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.95947719 |
47 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.95870536 |
48 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.95638812 |
49 | Poikilocytosis (HP:0004447) | 2.94620564 |
50 | Inability to walk (HP:0002540) | 2.93876739 |
51 | Generalized aminoaciduria (HP:0002909) | 2.90093763 |
52 | Abnormality of complement system (HP:0005339) | 2.89892063 |
53 | Nephronophthisis (HP:0000090) | 2.89174842 |
54 | Hyperammonemia (HP:0001987) | 2.85881425 |
55 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.83509490 |
56 | Hypoalphalipoproteinemia (HP:0003233) | 2.83294378 |
57 | Abnormality of glycolipid metabolism (HP:0010969) | 2.82246021 |
58 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.82246021 |
59 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.82246021 |
60 | Abnormality of purine metabolism (HP:0004352) | 2.81427384 |
61 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.81345903 |
62 | Dysostosis multiplex (HP:0000943) | 2.80674225 |
63 | Pendular nystagmus (HP:0012043) | 2.79765081 |
64 | Type II lissencephaly (HP:0007260) | 2.79703044 |
65 | Mutism (HP:0002300) | 2.79359898 |
66 | Hypercholesterolemia (HP:0003124) | 2.77888253 |
67 | Chronic hepatic failure (HP:0100626) | 2.77541598 |
68 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.76112085 |
69 | Hyperventilation (HP:0002883) | 2.75575884 |
70 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.73909924 |
71 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.73909924 |
72 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.73909924 |
73 | Abnormality of the renal cortex (HP:0011035) | 2.72987937 |
74 | Abnormal gallbladder morphology (HP:0012437) | 2.64702477 |
75 | Abolished electroretinogram (ERG) (HP:0000550) | 2.60478251 |
76 | Stomatitis (HP:0010280) | 2.58483898 |
77 | Hyperglycinemia (HP:0002154) | 2.58268249 |
78 | Hyperglycinuria (HP:0003108) | 2.57541980 |
79 | Abnormality of nucleobase metabolism (HP:0010932) | 2.56959395 |
80 | Systemic lupus erythematosus (HP:0002725) | 2.54005369 |
81 | Tubular atrophy (HP:0000092) | 2.51562668 |
82 | Abnormality of the renal medulla (HP:0100957) | 2.50160969 |
83 | Myocardial infarction (HP:0001658) | 2.50014077 |
84 | Attenuation of retinal blood vessels (HP:0007843) | 2.49075592 |
85 | Increased cerebral lipofuscin (HP:0011813) | 2.48794944 |
86 | Hepatocellular carcinoma (HP:0001402) | 2.48498144 |
87 | Retinal atrophy (HP:0001105) | 2.44808127 |
88 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.44167787 |
89 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.42029302 |
90 | Large for gestational age (HP:0001520) | 2.40251760 |
91 | Insulin resistance (HP:0000855) | 2.39680654 |
92 | Hypochromic microcytic anemia (HP:0004840) | 2.38418397 |
93 | Abnormality of methionine metabolism (HP:0010901) | 2.35845100 |
94 | Gout (HP:0001997) | 2.35016830 |
95 | Abnormality of glycine metabolism (HP:0010895) | 2.33544257 |
96 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.33544257 |
97 | Cholelithiasis (HP:0001081) | 2.32300409 |
98 | Progressive inability to walk (HP:0002505) | 2.32165761 |
99 | Global brain atrophy (HP:0002283) | 2.30463720 |
100 | Polyuria (HP:0000103) | 2.28970335 |
101 | Vacuolated lymphocytes (HP:0001922) | 2.25351592 |
102 | Hypomagnesemia (HP:0002917) | 2.24536975 |
103 | Metabolic acidosis (HP:0001942) | 2.20988720 |
104 | Irritability (HP:0000737) | 2.20692868 |
105 | Pancreatitis (HP:0001733) | 2.18809591 |
106 | Hypophosphatemia (HP:0002148) | 2.18162626 |
107 | Protuberant abdomen (HP:0001538) | 2.17948608 |
108 | Calf muscle hypertrophy (HP:0008981) | 2.17583648 |
109 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.16708238 |
110 | Gaze-evoked nystagmus (HP:0000640) | 2.16595752 |
111 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.16141600 |
112 | Clumsiness (HP:0002312) | 2.15155027 |
113 | Congenital sensorineural hearing impairment (HP:0008527) | 2.14754161 |
114 | Decreased central vision (HP:0007663) | 2.14298563 |
115 | Reticulocytosis (HP:0001923) | 2.13293520 |
116 | Medial flaring of the eyebrow (HP:0010747) | 2.12799079 |
117 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.11614354 |
118 | Osteomalacia (HP:0002749) | 2.11574571 |
119 | Elevated alkaline phosphatase (HP:0003155) | 2.11231241 |
120 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.10822186 |
121 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.08023416 |
122 | Glomerulonephritis (HP:0000099) | 2.07205059 |
123 | Anencephaly (HP:0002323) | 2.06147322 |
124 | Tetany (HP:0001281) | 2.05761865 |
125 | Protruding tongue (HP:0010808) | 2.05294565 |
126 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.05125339 |
127 | Abdominal distention (HP:0003270) | 2.03405423 |
128 | Abnormality of the gallbladder (HP:0005264) | 2.02680583 |
129 | Fair hair (HP:0002286) | 2.02594997 |
130 | Bilateral microphthalmos (HP:0007633) | 2.01550798 |
131 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.99634472 |
132 | Male pseudohermaphroditism (HP:0000037) | 1.96416711 |
133 | Colon cancer (HP:0003003) | 1.96245267 |
134 | Cystic liver disease (HP:0006706) | 1.95571123 |
135 | Congenital hepatic fibrosis (HP:0002612) | 1.94441393 |
136 | Mitral stenosis (HP:0001718) | 1.94398584 |
137 | Menorrhagia (HP:0000132) | 1.94040124 |
138 | Progressive cerebellar ataxia (HP:0002073) | 1.93217179 |
139 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.92642449 |
140 | Abnormality of urine glucose concentration (HP:0011016) | 1.92142692 |
141 | Glycosuria (HP:0003076) | 1.92142692 |
142 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.91412490 |
143 | Hypothermia (HP:0002045) | 1.90718716 |
144 | Cholecystitis (HP:0001082) | 1.89756171 |
145 | Abnormal gallbladder physiology (HP:0012438) | 1.89756171 |
146 | Abnormal biliary tract physiology (HP:0012439) | 1.89708579 |
147 | Bile duct proliferation (HP:0001408) | 1.89708579 |
148 | Inappropriate behavior (HP:0000719) | 1.89400198 |
149 | Limb hypertonia (HP:0002509) | 1.88468263 |
150 | Thyroid-stimulating hormone excess (HP:0002925) | 1.87871530 |
151 | Broad-based gait (HP:0002136) | 1.87110120 |
152 | Genetic anticipation (HP:0003743) | 1.86738026 |
153 | Death in childhood (HP:0003819) | 1.86112042 |
154 | Methylmalonic aciduria (HP:0012120) | 1.85696633 |
155 | Abnormal urine output (HP:0012590) | 1.85257260 |
156 | Increased corneal curvature (HP:0100692) | 1.84871692 |
157 | Keratoconus (HP:0000563) | 1.84871692 |
158 | Dialeptic seizures (HP:0011146) | 1.84576796 |
159 | Furrowed tongue (HP:0000221) | 1.82822592 |
160 | 3-Methylglutaconic aciduria (HP:0003535) | 1.82727756 |
161 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.81881454 |
162 | Steatorrhea (HP:0002570) | 1.80892353 |
163 | Disinhibition (HP:0000734) | 1.80517402 |
164 | Hydroxyprolinuria (HP:0003080) | 1.79344859 |
165 | Abnormality of proline metabolism (HP:0010907) | 1.79344859 |
166 | Dicarboxylic aciduria (HP:0003215) | 1.78786236 |
167 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.78786236 |
168 | Brushfield spots (HP:0001088) | 1.78640421 |
169 | Widely spaced teeth (HP:0000687) | 1.74640293 |
170 | Abnormality of the pons (HP:0007361) | 1.74439571 |
171 | Sclerocornea (HP:0000647) | 1.73430675 |
172 | Genital tract atresia (HP:0001827) | 1.72770448 |
173 | Febrile seizures (HP:0002373) | 1.71795673 |
174 | Increased CSF lactate (HP:0002490) | 1.70812475 |
175 | Decreased circulating renin level (HP:0003351) | 1.70457238 |
176 | Hypoplasia of the pons (HP:0012110) | 1.69338764 |
177 | Vaginal atresia (HP:0000148) | 1.69213575 |
178 | Tubulointerstitial fibrosis (HP:0005576) | 1.67625065 |
179 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.66287536 |
180 | Absent/shortened dynein arms (HP:0200106) | 1.66287536 |
181 | Azoospermia (HP:0000027) | 1.63121499 |
182 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.62445615 |
183 | Stomach cancer (HP:0012126) | 1.61977149 |
184 | Agnosia (HP:0010524) | 1.60715267 |
185 | Congenital, generalized hypertrichosis (HP:0004540) | 1.59323523 |
186 | Cerebellar dysplasia (HP:0007033) | 1.59075879 |
187 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.58841126 |
188 | Abnormality of renal excretion (HP:0011036) | 1.58750085 |
189 | Hypoplastic iliac wings (HP:0002866) | 1.58542111 |
190 | Abnormal protein glycosylation (HP:0012346) | 1.58067374 |
191 | Abnormal glycosylation (HP:0012345) | 1.58067374 |
192 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.58067374 |
193 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.58067374 |
194 | Metaphyseal irregularity (HP:0003025) | 1.57452662 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TAOK3 | 5.43818208 |
2 | INSRR | 5.23774465 |
3 | ERN1 | 4.24659004 |
4 | ACVR1B | 4.12749998 |
5 | MAPK15 | 4.12453280 |
6 | ADRBK2 | 3.62793014 |
7 | PIK3CG | 3.04531169 |
8 | BMPR1B | 2.79741276 |
9 | BCKDK | 2.65081714 |
10 | OBSCN | 2.64475205 |
11 | IRAK3 | 2.57450558 |
12 | FRK | 2.52713635 |
13 | WNK3 | 2.41104099 |
14 | TRIB3 | 2.30980085 |
15 | FLT3 | 2.26440787 |
16 | ZAK | 2.23478541 |
17 | PASK | 2.22829697 |
18 | NUAK1 | 2.13348507 |
19 | FGFR4 | 2.06417348 |
20 | TLK1 | 2.05440344 |
21 | TNIK | 1.99189836 |
22 | SIK1 | 1.98492503 |
23 | PTK6 | 1.97940063 |
24 | TAF1 | 1.90259146 |
25 | VRK2 | 1.83561126 |
26 | GRK1 | 1.79116121 |
27 | TYK2 | 1.75482319 |
28 | HIPK2 | 1.74660234 |
29 | PINK1 | 1.69617376 |
30 | PNCK | 1.67909831 |
31 | PHKG2 | 1.65040037 |
32 | PHKG1 | 1.65040037 |
33 | PKN2 | 1.62771857 |
34 | SCYL2 | 1.60424053 |
35 | MAP4K2 | 1.58673742 |
36 | MAP3K2 | 1.54646927 |
37 | TBK1 | 1.50713542 |
38 | CASK | 1.48137639 |
39 | GRK7 | 1.47292144 |
40 | VRK1 | 1.46460640 |
41 | JAK2 | 1.42717971 |
42 | BLK | 1.41206416 |
43 | MAP3K1 | 1.39239383 |
44 | WNK4 | 1.29907794 |
45 | TGFBR1 | 1.29505677 |
46 | MAP3K10 | 1.27040141 |
47 | TXK | 1.26949084 |
48 | JAK1 | 1.26570526 |
49 | MAP3K4 | 1.19440095 |
50 | RIPK1 | 1.17386819 |
51 | STK38L | 1.14989538 |
52 | DAPK2 | 1.09560620 |
53 | MAPK13 | 1.05523210 |
54 | PRKD3 | 1.05401241 |
55 | MATK | 1.05151010 |
56 | DYRK1B | 1.04255899 |
57 | ERBB4 | 1.02458525 |
58 | MKNK2 | 1.01326684 |
59 | OXSR1 | 1.01011448 |
60 | MAP2K6 | 1.00975837 |
61 | BRSK2 | 0.97907180 |
62 | EPHA3 | 0.96970475 |
63 | MAPK11 | 0.96806336 |
64 | STK39 | 0.96802285 |
65 | STK3 | 0.96353908 |
66 | CSK | 0.95178102 |
67 | DYRK3 | 0.95084587 |
68 | NEK9 | 0.91472903 |
69 | CSNK1G1 | 0.89285146 |
70 | CSNK1G2 | 0.88592011 |
71 | JAK3 | 0.87907946 |
72 | MAP3K3 | 0.87072076 |
73 | AKT3 | 0.85874075 |
74 | STK24 | 0.85873223 |
75 | MAP3K14 | 0.85863813 |
76 | MST1R | 0.84759183 |
77 | TYRO3 | 0.84539111 |
78 | CAMKK2 | 0.82990948 |
79 | TRIM28 | 0.82873073 |
80 | ZAP70 | 0.82825774 |
81 | IKBKE | 0.81139752 |
82 | CSNK1G3 | 0.80200693 |
83 | EIF2AK2 | 0.79382877 |
84 | WEE1 | 0.79212092 |
85 | PTK2 | 0.79173037 |
86 | PRKCG | 0.79106073 |
87 | LATS1 | 0.78972954 |
88 | MAPKAPK5 | 0.76868219 |
89 | CAMK1D | 0.75826153 |
90 | PRKAA1 | 0.75502488 |
91 | IRAK4 | 0.74726357 |
92 | CAMK4 | 0.73921194 |
93 | PDGFRA | 0.70914282 |
94 | CSNK1A1L | 0.70017210 |
95 | MARK3 | 0.69225328 |
96 | MAP2K3 | 0.68487280 |
97 | PRKCH | 0.68294174 |
98 | PKN1 | 0.66526623 |
99 | MAP4K1 | 0.65964602 |
100 | PRKAA2 | 0.65385461 |
101 | CDK6 | 0.64139351 |
102 | CAMK1 | 0.63008856 |
103 | MAP2K7 | 0.61559215 |
104 | DYRK2 | 0.60970716 |
105 | FGR | 0.60485986 |
106 | ITK | 0.59227234 |
107 | CHUK | 0.58676860 |
108 | IRAK1 | 0.58620766 |
109 | SGK2 | 0.58156387 |
110 | STK16 | 0.57513369 |
111 | MET | 0.57307644 |
112 | CHEK2 | 0.57180329 |
113 | EPHB1 | 0.56703116 |
114 | KIT | 0.56017690 |
115 | ADRBK1 | 0.56006195 |
116 | MAP2K2 | 0.55545114 |
117 | PRKCE | 0.54690154 |
118 | MTOR | 0.53930064 |
119 | GSK3A | 0.53115119 |
120 | FGFR2 | 0.51925973 |
121 | BTK | 0.51826269 |
122 | UHMK1 | 0.50907189 |
123 | ERBB3 | 0.50780970 |
124 | PRKACG | 0.50607113 |
125 | PLK4 | 0.50118604 |
126 | RPS6KA6 | 0.49785595 |
127 | ABL2 | 0.48989420 |
128 | FGFR3 | 0.47970508 |
129 | CSNK1A1 | 0.46909751 |
130 | MKNK1 | 0.45470745 |
131 | MAP3K5 | 0.45038862 |
132 | KDR | 0.43581054 |
133 | RET | 0.43366174 |
134 | CDK12 | 0.41591722 |
135 | EIF2AK3 | 0.40485325 |
136 | STK11 | 0.38965777 |
137 | TEC | 0.38240824 |
138 | SYK | 0.37914928 |
139 | PDPK1 | 0.36772882 |
140 | SGK3 | 0.36709713 |
141 | ERBB2 | 0.35753325 |
142 | MAPKAPK3 | 0.35518213 |
143 | MAP3K11 | 0.35273194 |
144 | PLK2 | 0.35220796 |
145 | RPS6KA5 | 0.35177122 |
146 | RPS6KA4 | 0.35156847 |
147 | CAMK2A | 0.34908480 |
148 | TGFBR2 | 0.34836572 |
149 | CSNK1D | 0.33374734 |
150 | CDC42BPA | 0.33143643 |
151 | CAMK1G | 0.33116915 |
152 | GRK6 | 0.32806665 |
153 | CLK1 | 0.32698776 |
154 | PRKCQ | 0.32387333 |
155 | IGF1R | 0.32304938 |
156 | LYN | 0.31712761 |
157 | EGFR | 0.31076143 |
158 | CDK4 | 0.30197372 |
159 | EIF2AK1 | 0.30104945 |
160 | SGK1 | 0.29329255 |
161 | PAK3 | 0.28450666 |
162 | PRKD2 | 0.27870555 |
163 | IKBKB | 0.27833867 |
164 | STK4 | 0.26796773 |
165 | TAOK1 | 0.24755928 |
166 | STK10 | 0.24301478 |
167 | KSR2 | 0.24004124 |
168 | PIM1 | 0.23767519 |
169 | BRD4 | 0.23153313 |
170 | NLK | 0.22692884 |
171 | PRKG2 | 0.22214160 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 5.11324427 |
2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.65355883 |
3 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.60351133 |
4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.93059412 |
5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.81484104 |
6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.62327327 |
7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.40899364 |
8 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.31618332 |
9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.30570813 |
10 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.30108270 |
11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.29931547 |
12 | Phototransduction_Homo sapiens_hsa04744 | 2.25855815 |
13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.18182650 |
14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.01583893 |
15 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.95988757 |
16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.95638054 |
17 | Homologous recombination_Homo sapiens_hsa03440 | 1.95567062 |
18 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.94099975 |
19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.88900629 |
20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.86506042 |
21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.86153256 |
22 | ABC transporters_Homo sapiens_hsa02010 | 1.85277377 |
23 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.84781605 |
24 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.82553038 |
25 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.81179441 |
26 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.79376883 |
27 | Peroxisome_Homo sapiens_hsa04146 | 1.76939689 |
28 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.73035401 |
29 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.71712512 |
30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.70061670 |
31 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.68279200 |
32 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.66948742 |
33 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.65395696 |
34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.64148559 |
35 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.62177147 |
36 | Asthma_Homo sapiens_hsa05310 | 1.61889037 |
37 | Basal transcription factors_Homo sapiens_hsa03022 | 1.60238290 |
38 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.57578133 |
39 | Protein export_Homo sapiens_hsa03060 | 1.55797482 |
40 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.54069771 |
41 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.51307524 |
42 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.50103277 |
43 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.47753732 |
44 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.45156463 |
45 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.44535347 |
46 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.41788693 |
47 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.37035192 |
48 | Bile secretion_Homo sapiens_hsa04976 | 1.35723021 |
49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.32338593 |
50 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.32160296 |
51 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.30975441 |
52 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.26643129 |
53 | RNA degradation_Homo sapiens_hsa03018 | 1.23916519 |
54 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.22687119 |
55 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.21906258 |
56 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.21179440 |
57 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.20371711 |
58 | Mineral absorption_Homo sapiens_hsa04978 | 1.19963092 |
59 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.19440803 |
60 | RNA polymerase_Homo sapiens_hsa03020 | 1.19001046 |
61 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.18166498 |
62 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.17811406 |
63 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.16929428 |
64 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.13864768 |
65 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.11521267 |
66 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.11071783 |
67 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.10577773 |
68 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.10524099 |
69 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.08437147 |
70 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.07340407 |
71 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.02686566 |
72 | Lysine degradation_Homo sapiens_hsa00310 | 1.00655449 |
73 | Retinol metabolism_Homo sapiens_hsa00830 | 0.97501049 |
74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.97314590 |
75 | Lysosome_Homo sapiens_hsa04142 | 0.94874191 |
76 | Allograft rejection_Homo sapiens_hsa05330 | 0.94489116 |
77 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.94316635 |
78 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.91461594 |
79 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.91120928 |
80 | Nicotine addiction_Homo sapiens_hsa05033 | 0.87924975 |
81 | Parkinsons disease_Homo sapiens_hsa05012 | 0.85893018 |
82 | Insulin resistance_Homo sapiens_hsa04931 | 0.85788723 |
83 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.84038042 |
84 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.81956834 |
85 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.81817296 |
86 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.80258447 |
87 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.79033860 |
88 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.77360890 |
89 | Galactose metabolism_Homo sapiens_hsa00052 | 0.77272440 |
90 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.75748899 |
91 | Sulfur relay system_Homo sapiens_hsa04122 | 0.73130406 |
92 | Carbon metabolism_Homo sapiens_hsa01200 | 0.72372304 |
93 | Insulin secretion_Homo sapiens_hsa04911 | 0.71316689 |
94 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.71263984 |
95 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.69658256 |
96 | Prion diseases_Homo sapiens_hsa05020 | 0.69532246 |
97 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.69005608 |
98 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.67129569 |
99 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.65796785 |
100 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.65402252 |
101 | Other glycan degradation_Homo sapiens_hsa00511 | 0.64252628 |
102 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.64018519 |
103 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.62213089 |
104 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.62140707 |
105 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.59305363 |
106 | Olfactory transduction_Homo sapiens_hsa04740 | 0.58675645 |
107 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.57113509 |
108 | Huntingtons disease_Homo sapiens_hsa05016 | 0.56993225 |
109 | Alzheimers disease_Homo sapiens_hsa05010 | 0.54320110 |
110 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.54032596 |
111 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54002392 |
112 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.53595381 |
113 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.51767295 |
114 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.51452445 |
115 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51084538 |
116 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.50552110 |
117 | Taste transduction_Homo sapiens_hsa04742 | 0.50125326 |
118 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49476287 |
119 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.48964532 |
120 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.47779561 |
121 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.46576882 |
122 | Legionellosis_Homo sapiens_hsa05134 | 0.46020382 |
123 | Tuberculosis_Homo sapiens_hsa05152 | 0.43783462 |
124 | Purine metabolism_Homo sapiens_hsa00230 | 0.42780602 |
125 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.42053337 |
126 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.41824638 |
127 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.38488357 |
128 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.38164912 |
129 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.37905419 |
130 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.37486321 |
131 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.35616155 |
132 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.35033179 |
133 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.34367505 |
134 | Metabolic pathways_Homo sapiens_hsa01100 | 0.32445980 |
135 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32260212 |
136 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.29172228 |
137 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.21355340 |
138 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.20723367 |
139 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.19042848 |
140 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.17122503 |
141 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.15958250 |
142 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.13418324 |
143 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.12780713 |
144 | Pertussis_Homo sapiens_hsa05133 | 0.12497780 |
145 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12430844 |
146 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.11580551 |
147 | Hepatitis C_Homo sapiens_hsa05160 | 0.11155034 |
148 | Circadian rhythm_Homo sapiens_hsa04710 | 0.09560810 |